Your session is about to expire
← Back to Search
Tele-Serotonin Reuptake Inhibitor for Depression (IPT Trial)
IPT Trial Summary
This trial will show whether interpersonal psychotherapy or a serotonin reuptake inhibitor is more acceptable to patients with breast cancer and depression, and whether one treatment is superior in reducing depression symptoms and inflammation.
IPT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIPT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IPT Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Which patients would be most likely to experience benefits from this clinical trial?
"The ideal patient for this study would have a diagnosis of breast cancer, be between 18-80 years old, and there are approximately 20 patients needed in total."
How many people are participating in this research study at the most?
"That is correct. The information available on clinicaltrials.gov verifies that this study, which was initially posted on March 1st 2022, has open recruitment at the moment. They are looking for 20 individuals from a single location to participate in the trial"
Does this experiment exclude anyone over the age of 18 from participating?
"According to the parameters set by the researchers, only patients aged 18 to 80 can qualify for this trial. Out of the 3232 clinical trials taking place for patients over 65, this study is just one. For people under 18 years old, there are a total of 190 different trials underway."
What conditions does Tele-Serotonin Reuptake Inhibitor help alleviate?
"Common mental health disorders that can be mitigated by Tele-Serotonin Reuptake Inhibitors include major depressive disorder, menopause-induced anxiety, and generalized anxiety disorder."
What are the risks associated with Tele-Serotonin Reuptake Inhibitor therapy?
"There is some evidence to support the Tele-Serotonin Reuptake Inhibitor's efficacy and safety, as this medication is in Phase 3 of clinical trials."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger